Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

ESSENTIALS: The role of statins in hemostasis and venous thromboembolism (VTE) prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin generation in patients with VTE. Endogenous thrombin potential and peak were decreased by 10% and 5% with rosuvastatin therapy. These...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thromb Haemost
Glavni autori: Orsi, Fernanda A., Biedermann, Joseph S., Kruip, Marieke J.H.A., van der Meer, Felix J., Rosendaal, Frits R., van Hylckama Vlieg, Astrid, Bos, Mettine H. A., Leebeek, Frank W. G., Cannegieter, Suzanne C., Lijfering, Willem M.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
CLINICAL HEMOSTASIS AND THROMBOSIS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://ncbi.nlm.nih.gov/pubmed/30565854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14364
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items